01530.HK
3SBio Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 13.54
−1.53%Margins
Gross margin
92.0%
EBITDA margin
64.1%
EBIT margin
61.2%
Net margin
46.4%
FCF margin
51.1%
30.0%
Return on equity
23.2%
Return on assets
37.7%
Return on invested capital
0.50x
Asset turnover
HKD 11.4B
Cash from operations
HKD 8.56
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026